Sanofi has a $50B biotech buyout budget, with Principia top of the list: report Ex-GSK Shingrix chief Pfefer lands at Flagship as its 2nd CEO-Partner Lilly's IL-23 drug beats Novartis' Cosentyx in plaque psoriasis Sponsored: Kupffer Cells in Complex In Vitro Cultures: An Important Tool For Drug Discovery FDA puts Merck's heart failure drug on priority review track Merck KGaA picks up another anticancer bispecific from F-star Thermo Fisher throws in an extra billion to buy COVID-19 testing supplier Qiagen Bolstered by immunology and oncology, J&J’s pharma business holds up under COVID-19 pressure FiercePharmaAsia—BeiGene's $2.1B share sale; Harbour's meaty C round; Lupin plant COVID-19 closure Chutes & Ladders—Vertex appoints BMS vet Atkinson to head manufacturing Featured Story | By Ben Adams Still augmenting its R&D and trying to drive innovation internally, French Big Pharma Sanofi is preparing to spend billions on biotechs to help further this cause. read more |
| |
|---|
|
| | Your clinical packaging strategy is key to a successful trial. When developing your strategy, it’s important to consider your patients' and healthcare providers' needs as well as packaging options and automation. Download our eBook to learn more. |
Top Stories By Amirah Al Idrus It’s back to biotech for Guillaume Pfefer, Ph.D., and not a moment too soon. Having spent four years at GlaxoSmithKline ushering its shingles vaccine through approval and onto the market, he’s now taking on the dual role of CEO-Partner at Flagship Pioneering, joining the biotech builder’s team while taking the helm at one of its startups, Kintai Therapeutics. read more By Amirah Al Idrus Eli Lilly’s anti-IL-23 antibody beat placebo at clearing psoriasis symptoms in a phase 3 study, teeing up regulatory filings across the globe. But that’s not all—the drug also outshone Novartis’ blockbuster Cosentyx in the same study. read more Monday, July 13, 2020 The inclusion of Kupffer cells in in vitro hepatic cultures provides researchers with advanced tools for disease modeling and drug discovery. read more By Nick Paul Taylor The FDA has granted priority review status to Merck’s vericiguat, teeing the Big Pharma to receive an approval decision early next year. Vericiguat, which Merck partnered on with Bayer in a $1 billion deal, will enter the increasingly congested heart failure market if the FDA gives it the green light. read more By Nick Paul Taylor Merck KGaA has exercised its option on a preclinical F-star Therapeutics immuno-oncology asset. The action, which F-star said came ahead of schedule, comes one year after Merck KGaA took up its option on another early-stage F-star molecule. read more By Conor Hale Thermo Fisher Scientific has sweetened its deal for diagnostic manufacturer Qiagen by about 10% after the spreading COVID-19 pandemic has heightened the value of molecular testing supplies. read more By Eric Sagonowsky With Johnson & Johnson being the first drugmaker to report earnings each quarter, market watchers have eagerly looked to the drugmaker's performance amid the pandemic to see how other biopharma players might fare. And in the second quarter, J&J posted growth in pharma despite COVID-associated challenges. read more By Angus Liu Amgen contributes $421 million to BeiGene's $2.1 billion share sale. Harbour BioMed, with COVID-19 antibody work, nabs $102.8 million in a series C round. Lupin shuts down an Indian plant after 18 employees tested positive for the novel coronavirus. And more. read more By Kyle Blankenship Vertex names Atkinson to head manufacturing; Scholar Rock CEO Mahanthappa steps away from role; Vor taps Lilly veteran as CMO. read more | | Webinar: Metabolites in Safety Testing (MIST): Analytical Strategy Wednesday, July 29 | 1pm ET / 10am PT Regulatory agencies have provided recommendations on when and how to identify and characterize drug metabolites to ensure their non-clinical toxicity has been adequately evaluated. This presentation will review the origins of these recommendations and the specific requirements that need to be considered in designing studies. Register now. |
Resources Sponsored by: Lonza Pharma & Biotech A novel spray-dried dispersion platform has been developed to faciliate high drug load applications Sponsored by: Florence Complimentary Download: How to connect to study sites remotely via the Electronic Investigator Site File (eISF) to streamline clinical operations. Insights from the largest eISF network in the world. Sponsored by: PRA Health Sciences Collaboration across the industry will be key to meeting the demands of the RACE Act and ensuring pediatric patients receive the care and treatments they need. Sponsored by: Cytiva On-demand video: fuel gene therapy development and production with modern AAV workflows. With today’s rapidly evolving environment, we have created this five-part content series to highlight pressing issues and topics that are more pertinent today than ever before. Sponsored by: Cambrex The industry trend of outsourcing to CDMOs continues. With more services, capabilities, facilities, and employees than ever before, our experts have contributed more articles to our biggest eBook yet. Sponsored by: EVERSANA How predictive analytics and machine learning have the potential to transform healthcare by predicting “Patient Switching Behaviors.” Sponsored by: Recro Gainesville Wurster processing is a versatile technique for developing and manufacturing multiparticulates for modified release dosage forms. Read this whitepaper to determine whether Wurster processing is the right option for your project. Sponsored by: Systech Get an inside look… Merck shares its next-generation approach to supply chain protection with new digital platforms, including Blockchain. Sponsored by: Automation Anywhere Built on advances in Artificial Intelligence (AI), data mining, and information integration into various systems at 100% accuracy, the new era of intelligent automation is integral to life sciences for devising new treatments faster and at a lower expense. Sponsored by: Research Solutions Learn four ways to squeeze more value from your limited R&D resources. Sponsored by: BioAnalytix Download this eBook and Learn the Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. The Bioprocessing Summit Virtual – Solving Today’s Challenges, Leading to Tomorrow’s Advances August 24-28, 2020 Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training ongoing now. | COVID19 provisions – training will be on-site as normal. | New – may be possible for some individuals to access the training virtually in real time. | 